Global Metastases Spinal Tumor market continues to demonstrate steady expansion driven by rising cancer prevalence, advancements in non-invasive therapies, and increased focus on precision oncology. Valued at USD 1,085 million in 2024, the market is expected to grow to USD 1,128 million in 2025, eventually reaching USD 1,409 million by 2032, reflecting a CAGR of 3.9% during the foreca... https://www.24lifesciences.com/metastases-spinal-tumor-market-9532